This page has moved. Click here to view.
Topics in Pulmonary Disease
Pleural Effusion
I. Diagnostic evaluation of Pleural Effusion
A. Classification of transudate vs. exudate
1. Criteria for exudate - pleural fluid/serum protein >0.5; pleural
fluid/serum LDH >0.6; or absolute LDH >2/3 upper limits of normal
serum level
2. Implications: transudate related to change in hydrostatic and oncotic
pressure balance; exudate related to change in pleural permeability
B. Cell count
RBCs - bloody effusion suggestive of trauma, malignancy, or pulmonary infarction
Lymphocytes - overwhelming predominance of mature
lymphocytes suggestive of TB. Other potential diagnoses -
lymphoma, sarcoidosis, chronic rheumatoid pleurisy, carcinoma
Eosinophils - most commonly following previous blood or air in pleural space
C. Glucose
Lowest in RA, empyema
Can be low in TB, malignancy, lupus, esophageal rupture
pH
Tends to be low in conjunction with low glucose
Prognostic implication for development of complications (1oculations) in parapneumonic effusion
Definition of chylothorax - triglycerides >110 mg/dl. If borderline
triglycerides (50-110 mg/dl), chylomicrons on lipoprotein
electrophoresis of fluid are diagnostic of chylothorax
Specific causes of pleural effusions
TB - presence of effusions in primary vs. reactivation disease
Cirrhosis - commonly secondary to leakage of ascitic fluid through diaphragmatic defects
D. Pulmonary emboli - any type of effusion possible
E. Drugs - pleuropulmonary disease described in patients taking
bromocriptine for Parkinson's disease; can get effusions, pleural thickening, pulmonary infiltrates
Pleural biopsy
A. Main usefulness when TB suspected
1. Importance of culture and histology of biopsy
B. Less usefulness for supplementing results from pleural fluid cytology
V. Selected aspects of diagnosis and management
B. Sclerosis (pleurodesis) - generally with minocycline or doxycycline
(tetracycline no longer available); can be done through chest tube or small
bore catheter
Pleuroperitoneal shunting - an alternative for palliation of dyspnea if other
therapy not effective or not appropriate
1. May be the treatment of choice for